uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted October 24, 2012

Warning Issued to Memory Supplement Maker For Unapproved Drug Ingredient, Drug Claims and Unreported Adverse Events

On October 16, 2012, the FDA issued a letter to dietary supplement manufacturer Quincy Bioscience Manufacturing Inc., warning that the company's memory and brain health supplements Prevagen, Prevagen Extra Strength, and Prevagen Professional do not qualify as dietary supplements under current federal regulations and have been found to be unapproved new drugs.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at